These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8503311)

  • 1. Guillain-Barré syndrome in Oxfordshire: clinical features in relation to age.
    Winner SJ; Evans JG
    Age Ageing; 1993 May; 22(3):164-70. PubMed ID: 8503311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients.
    Lyu RK; Tang LM; Cheng SY; Hsu WC; Chen ST
    J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):494-500. PubMed ID: 9343130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of the Guillain-Barré syndrome.
    Soffer D; Feldman S; Alter M
    J Neurol Sci; 1978 Jun; 37(1-2):135-43. PubMed ID: 690663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and nerve conduction features in Guillain-Barré syndrome associated with Zika virus infection in Cúcuta, Colombia.
    Uncini A; González-Bravo DC; Acosta-Ampudia YY; Ojeda EC; Rodríguez Y; Monsalve DM; Ramírez-Santana C; Vega DA; Paipilla D; Torres L; Molano-González N; Osorio JE; Anaya JM
    Eur J Neurol; 2018 Apr; 25(4):644-650. PubMed ID: 29266602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-associated changes in the symptomatology of Guillain-Barré syndrome in children.
    Sakakihara Y; Kamoshita S
    Dev Med Child Neurol; 1991 Jul; 33(7):611-6. PubMed ID: 1652528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent Guillain-Barré syndrome.
    Kuitwaard K; van Koningsveld R; Ruts L; Jacobs BC; van Doorn PA
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):56-9. PubMed ID: 18931012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of early beneficial response to plasma exchange in Guillain-Barré syndrome.
    Gruener G; Bosch EP; Strauss RG; Klugman M; Kimura J
    Arch Neurol; 1987 Mar; 44(3):295-8. PubMed ID: 3827680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome. A prospective clinical study in 25 children and comparison with adults.
    Sarada C; Tharakan JK; Nair M
    Ann Trop Paediatr; 1994; 14(4):281-6. PubMed ID: 7880089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
    Verma R; Chaudhari TS; Raut TP; Garg RK
    J Neurol Sci; 2013 Dec; 335(1-2):105-11. PubMed ID: 24064258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome in the elderly.
    Peric S; Berisavac I; Stojiljkovic Tamas O; Rajic S; Babic M; Cvijanovic M; Dominovic-Kovacevic A; Basta I; Beslac-Bumbasirevic L; Lavrnic D
    J Peripher Nerv Syst; 2016 Jun; 21(2):105-10. PubMed ID: 26880714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term prognosis of Guillain-Barré syndrome. Evaluation of prognostic factors including plasma exchange.
    Vedeler CA; Wik E; Nyland H
    Acta Neurol Scand; 1997 May; 95(5):298-302. PubMed ID: 9188906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe dysautonomic onset of Guillain-Barré syndrome with good recovery. A clinical and autonomic follow-up study.
    Cortelli P; Contin M; Lugaresi A; Baruzzi A; Montagna P
    Ital J Neurol Sci; 1990 Apr; 11(2):159-62. PubMed ID: 2361852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual health status after Guillain-Barré syndrome.
    Bernsen RA; Jacobs HM; de Jager AE; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):637-40. PubMed ID: 9219755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Landry-Guillain-Barré syndrome. Study of prognostic factors in 223 cases].
    Raphael JC; Masson C; Morice V; Brunel D; Gajdos P; Barois A; Goulon M
    Rev Neurol (Paris); 1986; 142(6-7):613-24. PubMed ID: 3797932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain in Guillain-Barré syndrome.
    Ropper AH; Shahani BT
    Arch Neurol; 1984 May; 41(5):511-4. PubMed ID: 6721720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence, clinical manifestations, and prognosis of Guillain-Barré syndrome.
    Rantala H; Uhari M; Niemelä M
    Arch Dis Child; 1991 Jun; 66(6):706-8; discussion 708-9. PubMed ID: 2053793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group.
    Visser LH; Van der Meché FG; Van Doorn PA; Meulstee J; Jacobs BC; Oomes PG; Kleyweg RP; Meulstee J
    Brain; 1995 Aug; 118 ( Pt 4)():841-7. PubMed ID: 7655882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rehabilitation of Guillain-Barré syndrome.
    Meythaler JM
    Arch Phys Med Rehabil; 1997 Aug; 78(8):872-9. PubMed ID: 9344309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of taste in the Guillain-Barré syndrome.
    Soria ED; Candaras MM; Truax BT
    Clin Neurol Neurosurg; 1990; 92(1):75-9. PubMed ID: 2154360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.